Aim: To explore the effects of Baicalin and Ligustrazine on airway inflammation and construction and underlying mechanisms through the expressions of GATA-3, IL-5, MMP-9 and TIMP-1 in asthmatic rats. Methods: 30 Wistar rats were randomly divided equally into five groups. Lung tissues were sliced. WBC and Eos in lung tissue were estimated by HE stain and the expressions of IL-5, GATA-3, MMP-9, TIMP-1 and collagen type IV in lung tissue were observed by immunohistochemistry. The airway wall and airway smooth muscle thicknesses were measured by computed image analysis system. Results: Compared with asthma group, EOS counts and the expression of IL-5 and GATA-3 in the lung tissue were significantly lower in normal controlled groups (P < 0.05 or P < 0.01). Additionally, the thickness of airway wall and airway smooth muscle did significantly increase, and the expressions of collagen type IV, MMP-9 and TIMP-1 were significantly higher in asthma group (P < 0.05). With the intervention of Baicalin or Ligustrazine, EOS decreased, and the thicknesses of airway wall and airway smooth muscle became thinner compared with asthma group. Meanwhile, the expression of collagen type IV, IL-5, GATA-3, MMP-9 and TIMP-1 significantly decreased (P < 0.05). Airway wall thickness and collagen type IV were associated with Eos, IL-5, TAGA-3, MMP-9, TIMP-1 and MMP-9/TIMP-1. Conclusion: Two herbs could diminish infiltration of EOS with inhibiting the expressions of IL-5, and GATA-3, meanwhile, decrease the deposition of collagen type IV and the thickness of the airway smooth muscle through regulating MMP-9, TIMP-1 level and the balance between MMP-9 and TIMP-1, additionally, had synergetic effects.
INTRODUCTION
Asthma is a chronic airway inflammatory disease characterized by airway remodeling and reversible airflow obstruction and involved the infiltrations of eosinophiles (EOS), mast cells, T lymphocytes and cytokines. Airway inflammation and remodeling are two important pathophysiologic processes of asthma. The airway tissue injury and repair from acute and chronic airway inflammation resulted in airway remodeling, which was a main cause of irreversible airflow obstruction and a factor that made it difficulty to treat the patients with asthma. In addition, airway remodeling aggravated airway inflammation in asthma, vice versa, in this way, those two pathological processes were impacted each other [1] . In asthmatic patients, EOS is a crucial effect cell for the particular inflammation in airway mucous membrane, even so, IL-5 plays an essential role in the inflammation, for IL-5 could regulate EOS function through GATA-3 known as a transcription factor in TH2 lymphocytes, and IL-5 makes EOS recruiting, activating, chemotaxis in the inflammation site [2] . Many components involved in airway remodeling, including disorder of Extra cellular matrix (ECM) degradation and deposition, hyperplasia of smooth muscle in asthma. Matrix metalloproteinases were main limited enzymes to regulate ECM metabolism and influenced ECM deposition and hyperplasia of smooth muscle [1] . So far, there has been no efficient approach to treat or cure airway remodeling in asthma. Herb is the Chinese traditional medicine, and plays the peculiar parts in preventing and treating the patients with asthma. Though herb had little side effect in treating diseases, refining herb was so difficult. This experiment chose two herbs (Baicalin and Ligustrazine) refined, and observed the infiltration of EOS, the expressions of IL-5 and GATA-3, airway construction, thickness of smooth muscle, the expressions of collagen type IV, MMP-9 and TIMP-1 in rat model with asthma. Through the study, we explore those herbs' effects on airway inflammation and airway remodeling and underlying mechanism in asthma.
MATERIALS AND METHODS

Animals
Thirty healthy male wistar rats (weighing 200 ± 20 g) were from the animal center of Shanxi Medical University. They were kept in clean environment, and room temperature and humidity were set at 22˚C -25˚C and 40% -70% respectively and the animals were provided food and tap water. 30 health male wistar rats were randomly divided equally into five groups: controlled group, asthma group, Baicalin group, Ligustrazine group and Baicalin added with Ligustrazine group, 6 rats each group. All animal experimental procedures were performed under the guideline of Shanxi Medical University Animal Experiment. All animal experimentations were approved by Shanxi Association for Laboratory Animal Science, Taiyuan, China.
Reagents, Apparatus and Medicines
Ovalbumin (OVA) was bought from Sigma Company. Multiple cloning antibodies of GATA-3, IL-5, Matrix metalloproteinase-9 (MMP-9), Tissue inhibitor of metalloproteinase-1 (HIMP-1), collagen type IV, SABC and DAB reagents boxes were bought from Boster Biological Technology Co. Ltd., Wuhan, China. Injection Baicalin were from Chengtu Master's Limited Company of Bioscience and Biotechnology (Chentu, China), and its molecular formula was C 8 H 12 N 2 ·HCl·2H 2 O, and its molecular weight was 208.69 (HPLC ≥ 98%, 20 mg each ampoule). Injection Ligustrazine was from Yongkang Pharmic Limited Company (Beijing, China), and its molecular formula was C 21 H 18 O 11 . Its molecular weight was 446.36 (40 mg each ampoule). 980 ultrasonic atomizer was bought from Iatrical Equipment Company limited. Computed image analysis system was provided by The Pathological Department of Shanxi Medical University (Taiyuan, China).
Asthmatic Model and Intervention of
Baicalin and Ligustrazine
Referred to Holgate's method, rats were immunized intraperitoneally (i.p.) with 1 ml 10% OVA (Sigma company) mixed with Aluminum hydroxide 200 mg on day 1 and boosted in the same way on day 8. On day 14 -42, rats received an intranasal (i.n.) challenge with 1% OVA for 30 min once a day. Intervention groups: Baicalin group: on day 14 -42, the rats were injected intraperitoneally with Baicalin injection 5 mg every day within half an hour before the challenge. Ligustrazine group: during the same period, the rats were injected intraperitoneally with Ligustrazine injection 5 mg. and Baicalin added with Ligustrazine group: the rats were injected intraperitoneally with Ligustrazine injection 2.5 mg and Baicalin injection 2.5 mg respectively.
Controlled group: the rats were immunized with isotonic brine replaced 1% OVA. It was the mark of asthmatic model then the rats had dyspnea, lip's cyanosis, abdominal rigidity, nodded breathing, lack of stability and stiffness.
Pulmonary Tissues Collecting and Processing
On 42 day, all animals were sacrificed within 24 hours after the last challenge. Lungs were excised from rats, and the right lobe was fixed by 4% paraformaldehyde, dehydrated using series of graded ethanol. Tissues were embedded in paraffin, and sliced as 5 μm section.
Airway Wall and Smooth Muscle Thickness Measuring and EOS Counting
Slides were stained with H&E and their pathological findings were observed. Ten different high power objective visual fields were chosen at random under the microscope, and EOS were counted. On the airway with diameter 200 ± 10 μm, the thicknesses of the airway wall and smooth muscle were measured by using computed image analysis system.
MMP-9, TIMP-1, GATA, IL-5 and Collagen IV Half-Quality Assay by Immunohistochemistry
SABC method: slides were de-waxed, and the endogenous peroxidase was inactivated with 3% H 2 O 2 . The antigens were repaired by microwave. After the addition of the first antibody of MMP-9, TIMP-1, GATA, IL-5 and collagen IV, the sections were left overnight in working liquid wet box at 4˚C, rinsed with PBS, made to react with the second biotinized antibody for 30 min at 37˚C, disposed for 30 min at 37˚C with streptomycintropin labeled with horseradish peroxidase. After rinsing, the sections were visualized with diamidobianilin (DAB), re-stained with haematoxylin, dehydrated, mounted and observed. PSA replaced the first antibodies in negative control group. Ten different high power objective visual fields were chosen at random under the microscope, and the sections were analyzed by using computed image analytical system. Criteria: negative as no color, weak positive as wheat color, positive as yellow, strong positive as brown.
Statistical Analysis
All data were presented as mean ± standard deviation (SD). The results were compared by one way analysis of variance (AVONA). The differences between groups were analyzed with LSD method. Multiple Liner regression analysis was employed to analyze the relationship among the parameters (stepwise). SPSS 11.0 software package was used for the evaluation of the statistical significance of the data. Differences were considered significant at P < 0.05.
RESULTS
Pathomorphological Changes
There were no inflammation changes in controlled group, however, there were smooth muscle hypertrophy and hyperplasia, thickened basement membrane and airway wall, infiltration of bronchial and parabronchial tissue with lymphocytes and eosinophils, increased plica mucosa, desquamation of epithelium and the narrow of airway lumen in asthma group. In addition, there were less inflammation in Baicalin, Ligustrazine group and Baicalin added with Ligustrazine group than those in asthma group (Figures 1-5 ).
The Ratio of Airway Wall Luminal to Outer Diameters, the Thicknesses of Smooth
Muscle and Collagen Type IV (Table 1) The thicknesses of airway wall and smooth muscle were Figure 1 . There was no significant inflammation in controlled group, including no infiltration of bronchial and parabronchial tissues with inflammation cell such as eosinophiles, monocytes and lymphocyte, no smooth muscle hypertrophy and hyperplasia, thickened basement membrane, mucus plug, and desquamation of epithelia in airway. than those in Baicalin added with Ligustrazine group; furthermore, collagen IV was higher in asthma group than those in the other groups, as illustrated in Table 1. 3.3. EOS Counts, the Expression of GATA-3 and IL-5 in Lung Tissues (Table 2) EOS count was higher in asthma group than those in the other groups, and EOS count was lower in controlled group than those in the other groups, as also, GATA-3 and IL-5 expressions in lung tissues were higher in asthma group than in the other groups ( Table 2) . (Table 3 ) Figure 5 . No significant inflammation was found in Baicalin added with Ligustrazine group; there was no significant difference in pathological changes, compared with the controlled group.
The Expressions of MMP-9 and TIMP-1 and MMP-9/TIMP-1 in Lung Tissues
The expressions of MMP-9 and TIMP-1 in lung tissues were higher in asthma group than those in the other groups. MMP-9/TIMP-1 was normal in controlled group and Baicalin added with Ligustrazine group, but it was ot normal in the other groups ( Table 3) .
thicker in asthma group than those in the other groups, and were thicker in Baicalin and Ligustrazine group n Table 1 . The ratio of airway wall luminal to outer diameters, the thicknesses of smooth muscle and collagen type IV. Compared with controlled group, ▲ P < 0.000, compared with asthma group, △ P < 0.000, compared with Baicalin group, ＃ P < 0.01, compared with Ligustrazine group, ＊ P < 0.000. 
Multiple Liner Regression Analysis for EOS, Thickness of Smooth Muscle and
DISCUSSION
Asthama is a serious global disease that cannot be cured effectively so far. Both inhaled glucocorticosteroids and β 2 -agonists are considered as two effective medicines to treat asthma. However, the shortcomings brought by them cannot be ignored. For example, both two medicines have side effects and it is still not clear that they can improve the airway remodeling. Herb, as the traditional Chinese medicine, has significant advantages such as little side effects and more focuses on the balance between location and the whole body. But the deficiency of hard to extract is the main obstruction of putting herb into practice. However, Baicalin and Lingustrazine have the feature of extracting easily which are not shared by most of the herbs. The following is going to discuss how the two medicines control the airway inflammation and improve airway remodeling.
Bronchial asthma is an allergic disease characterized with airway inflammation, airway remodeling and airway hyperresponsiveness. Chronic airway inflammation was considered as the essential of asthma, and EOS played an important role in chronic airway inflammation which was associated with asthma severeness [3] . In addition, IL-5 played a key part in activating EOS and regulating EOS function, and could specifically induce EOS and make EOS growing, differentiating and having activities [4] . Airway remodeling of bronchial asthma involved the subepithelial collagen deposition, thickened basement membrane and smooth muscle hypertrophy or hyperplasia in the biopsy of bronchial mucosa in patients with asthma. Airway structure change and airflow obstruction could not be improved through anti-inflammation medication and bronchodilator so it resulted in airway remodeling which aggravated airway narrow, airflow resistance, and airway hyperresponsiveness [5] .
The extracellular matrix (ECM) in the bronchial wall was recently reported to be an important component in the maintenance of histological homeostasis of airway tract by balancing synthesis and degradation of the structural component of the composition. Balance between MMPs and TIMPs is a determinant to maintain the balance between synthesis and degradation of ECM [6] . MMP-9 and TIMP-1 are main members in MMPs and TIMPs families respectively. MMP-9 could degrade ECM, and TIMP-1 is the physiological inhibitor of MMP-9. Normal cells secret MMP-9 and TIMP-1 in the ratio of 1 to 1, and they combined dissoluble non-covalence with each other, which is irreversible and stable. In addition, the research showed that the balance between MMP-9 and TIMP-1 was associated with airway remodeling in asthma [6] .
Baicalin is one kind of herbs, and acts as anti-inflammation and against allergy. The reports found that Baicalin could decrease the EOS count in BALF, sputum and blood and WBC count in BALF in sensitized Guinea pig [7] . Ligustrazine is a herb too, it can improve circulation of blood and anticoagulation, and treated the patients with COPD, cardiac-encephalic vascular diseases, thromboembolism disease [8] . A few reports represented the two herbs could treat airway inflammation and remodeling in patients with asthma.
This experiment found that the ratio of luminal to outer airway diameter was fewer in asthma group than in the other groups; meanwhile, the thicknesses of smooth muscle and the expression of collagen IV were higher in asthma group than in the other groups. The intervention with Baicalin and Ligustrazine made the thicknesses of smooth muscle and the expression of collagen IV decreased, and ratio of luminal to outer airway diameter increased. Furthermore, the thickness of smooth muscle was thinner in Baicalin added with Ligustrazine group than in Baicalin group and Ligustrazine group, which proved that Baicalin and Ligustrazine had a synergetic effect on ameliorating the thickness of smooth muscle.
This study proved that two herbs reduced airway inflammation (decreased Eosinophil infiltration of airway) through inhibiting expressiones of GATA-3 and IL-5. The experiment results found that EOS, GATA-3 and IL-5 were higher in asthma group than in the other groups. GATA-3 and EOS were higher in Baicalin and Ligustrazine groups than in Baicalin added with Ligustrazine group, and IL-5 was higher in Baicalin group than in Baicalin added with Ligustrazine group. The recent research showed that GATA-3 was a specific transcription factor of TH 2 lymphocyte, and induced TH 2 lymphocyte to secrete cytokine. Inhibiting the expression of GATA-3 can decrease the inflammation of airway led by TH 2 lymphocyte [9, 10] . These results did also confirm that Baicalin and Ligustrazine could decrease the Eosinophil infiltration of airway by inhibiting the expressiones of GATA-3 and IL-5. In addition, Baicalin added with Ligustrazine group excelled Baicalin and Ligustrazine groups at decreasing EOS infiltration and the expressions of GATA-3 and IL-5. Two herbs had synergetic effect.
This experiment showed that the expressions of MMP-9 and TIMP-1 in the airway wall of rats were higher in asthma group than in the other groups, and the ratio of MMP-9/TIMP-1 was abnormal in asthma group, and it was significantly lower than in both controlled group and Baicalin added with Ligustrazine groups. The ratio of MMP-9/TIMP-1 was normalized in Baicalin added with Ligustrazine group. However, the ratio of MMP-9/ TIMP-1 in Baicalin group and Ligustrazine group was not significant compared with asthma group, so the intervention of Baicalin added with Ligustrazine could have a synergetic effect in regulating the ratio of MMP-9/TIMP-1.
Studies showed that MMP-9, TIMP-1 and MMP-9/ TIMP-1 played crucial roles in airway remodeling [8, 9] .
To understand underlying mechanism of airway inflammation and remodeling, multiple liner regression analysis was made. ESO infiltration of airway was presented as the characteristic of airway inflammation, and the thickness of smooth muscle and the content of collagen IV were presented as the marks of airway remodeling. Furthermore, their metabolism was influenced with airway inflammation and remodeling cytokines. Multiple liner regression analysis found the positive correlation between EOS and IL-5 and MMP-9, which showed that airway inflammation cytokine (IL-5) was associated with EOS infiltration of airway, in addition, EOS increasing with higher expression of MMP-9 proved airway inflammation associated with ECM degraded. There were the positive correlations between the thickness of smooth muscle and TIMP-1, MMP-9/TIMP-1 and EOS, however, and the negative correlation between the thicknesses of smooth muscle and MMP-9, collagen IV, and GATA-3, meanwhile, the positive correlation between the expressions of collagen IV and TIMP-1, MMP-9/TIMP-1, IL-5, nevertheless, the negative correlation between the expressions of collagen IV and MMP-9. Those results showed that the higher expression of TIMP-1 and the abnormal ratios of MMP-9/TIMP-1 increased the thickness of smooth muscle and the expression of collagen IV, however, the higher expression of MMP-9 decreased them. The result proved that MMP-9 degraded ECM, and TIMP-1 inhibited activity of MMP-9. In addition, these results also proved that airway inflammation (EOS infiltration) induced higher expression of MMP-9, then the expression of TIMP-1 did compensative increased, so that MMP-9/TIMP-1 kept from unbalance to balance. In same way, repeated airway inflammation and asthma exacerbation made MMP-9/TIMP-1 unbalance and balance in turn. Finally, these pathological changes resulted in the decompensation of collagen (deposition of collagen IV), the hypertrophy of smooth muscle and the changes of airway structure, teamed airway remodeling. Those results were similar to Xu's [11] and Hoshino's [12] ones. The results manifested that EOS infiltration of airway, the thickness of smooth muscle and the content of collagen IV played an important part in airway inflammation, maintaining airway structure and airway remodeling respectively. With the intervention of Baicalin and Ligustrazine, the expressions of MMP-9 and TIMP-1 were decreased, and MMP-9/TIMP-1 tended to be normal. In addition, MMP-9/TIMP-1 in Baicalin added with Ligustrazine group was not significant compared with controlled group, but significant compared with asthma group. However, MMP-9/TIMP-1 in both Baicalin group and Ligustrazine group was not significant compared with asthma group, so the result proved that Baicalin and Ligustrazine had synergetic effect on regulating MMP-9/TIMP-1.
In summary, the results found that EOS infiltration in airway in asthma group was more than in the other groups; smooth muscle thickness in asthma group was thicker than in the other groups; the expression of collagen IV in asthma group was higher than in the other groups. Baicalin and Ligustrazine could inhibite airway inflammation, decrease smooth muscle thickness, diminish the deposition of collagen IV and increase the ratio of luminal to outer airway diameter through regulating airway inflammation cytokine (IL-5, GATA-3), infiltration of EOS and airway remodeling cytokine (MMP-9, TIMP-1 and MMP-9/TIMP-1). Furthermore, Baicalin and Ligustrazine had synergetic effect on treating asthma, especially airway remodeling of asthma, and both herbs will be the effective medicines for treating asthma in future.
CONCLUSION
Airway inflammation and airway wall remodeling were two important aspects in asthma, and they were influenced by each other. Eos counts and the expression of IL-5 and GATA-3 in the lung tissues in asthma group were significantly higher than the other groups; meanwhile, the expressions of MMP-9 and TIMP-1 significantly were higher too. Additionally, the thicknesses of airway wall and airway smooth muscle in asthma group significantly increased. After intervention with Baicalin or Ligustrazine, the thicknesses of airway wall and airway smooth muscle became thinner than those in asthma group, at the same time, the expression of MMP-9 and TIMP-1 significantly decreased. Smooth muscle thickness and collagen type IV were associated with EOS, IL-5, TAGA-3, MMP-9, TIMP-1 and MMP-9/TIMP-1. Two herbs could inhibit the expressions of IL-5 and GATA-3 and the infiltration of EOS and decrease the deposition of collagen type IV and reduce the airway smooth muscle thickness through regulating MMP-9 and TIMP-1 level and influencing the balance between MMP-9 and TIMP-1, and had synergetic effect. This will provide new therapeutic way to asthmatic patients.
